DocDollars

Tandem Diabetes Care, Inc.

CA · United States · Reporting entity ID 100000010651

Total reported 2019–2025
$21.4M
#304 of 2,960 reporting companies — 0% of all reported industry payments
$9.79M in general payments across 52,685 records, plus $11.6M in research funding across 144 records.

How it breaks down

General payments $9,789,652
Research funding $11,631,536

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Tandem Diabetes Care, Inc. reported $21.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #304 of 2,960 reporting companies. 54% of that was research funding and 46% general payments such as consulting, speaking, food and travel. 52,685 general payment records and 144 research records were filed.

Common questions about Tandem Diabetes Care, Inc.

How much has Tandem Diabetes Care, Inc. paid US doctors?

Tandem Diabetes Care, Inc. reported $21,421,189 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $9,789,652 in general payments, $11,631,536 in research funding.

How does Tandem Diabetes Care, Inc. rank among drug and device companies?

It ranks #304 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Tandem Diabetes Care, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.